-
HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit
- 2025/04/21
- 再生時間: 1 時間 40 分
- ポッドキャスト
-
サマリー
あらすじ・解説
Clinical investigators discuss available data guiding the management of HER2-positive, triple-negative and localized breast cancer.
CME information and select publications here.